Prevention of Venous Thromboembolism
- 1 January 2001
- journal article
- review article
- Published by Elsevier BV in Chest
- Vol. 119 (1), 132S-175S
- https://doi.org/10.1378/chest.119.1_suppl.132s
Abstract
No abstract availableThis publication has 493 references indexed in Scilit:
- A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsNew England Journal of Medicine, 1999
- Incidence and risk of thromboembolism during treatment of high-grade gliomas: a prospective studyEuropean Journal Of Cancer, 1997
- The Venous Thrombotic Risk in Nonsurgical PatientsDrugs, 1996
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast CancerNew England Journal of Medicine, 1988
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Adjusted versus Fixed-Dose Subcutaneous Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 1983
- Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous ThrombosisNew England Journal of Medicine, 1979
- Aspirin Prophylaxis of Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1977